Introduction to


The existence of two or more chronic illnesses, which may be related to one’s physical or mental health. It is a growing global health issue.

Estimates of the prevalence trend in LMICs ranges from 3.2% to 90.5%. (Abebe et al. (2020).  37% of South Asian individuals over 60 who live in cities are anticipated to be affected (Singh et al.,2019).

Increased disability, higher mortality, poorer functionality, quality of life, and poorer mental health are the results of this. We in this group strive to lessen these limitations, and in the process, we create research studies that are based on reliable data to affect societal improvements.

Study Information

Improving Access to Pulmonary Rehabilitation for South Asians living with COPD in the UK.

The Multimorbidity group is interested in improving access to, and engagement with, Pulmonary Rehabilitation for South Asians with COPD in the UK. Pulmonary Rehabilitation is a gold standard treatment for COPD, but referral and uptake rates are low. South Asians make up over 5% of the UK population and the COPD prevalence is thought to be around 1.5% within this group. However, South Asians with COPD are underrepresented within Pulmonary Rehabilitation services. It’s thought that this is due to a number of specific barriers which should be better identified and resolved to ensure equitable access to this important treatment.

The multimorbidity group are currently engaged in consultation with patients and health professionals to explore their needs in this area. They will then collaborate with national experts in COPD as well as the South Asian community to identify and test strategies to increase access and engagement to Pulmonary Rehabilitation.


Prof. Nusrat Husain

Profile will be added by Mahnoor

Dr. Munazza S Obaid

Dr. Munazza Suharwardy Obaid is an MBBS from Baqai Medical College in 1996. She acquired her Membership of the College of Physicians & Surgeons in Community Medicine in 2015 and Masters of Science of Public Health in 2019 from Jinnah Sindh Medical University. She has been in teaching Undergraduate and postgraduate students of MBBS, Nursing, and Physiotherapy for 11 years in varied renowned Medical Universities in Pakistan and UK and is affiliated with University of Central Lancashire (UCLAN). She is an Honorary Research Associate at the University of Manchester also.

She has published papers in peer-reviewed journals and her interests are Multimorbidity, Bio-ethics, Medical Education, and Primary Health care along with mental health. Has presented papers at national and international conferences..

She is part of the Pakistan Institute of Living and learning for 5 years and has been part of the Biostatistics group, Bioethics and governance group, Substance use disorder group, Multimorbidity group and varied projects of PILL such as SAHAR M. Her interest in media has earned her the title of lead web page developer in Bioethics and governance group and is also helped developing pages for Substance use disorder as well as the Multimorbidity group.

Dr. Amy Blakemore

Dr Amy Blakemore is co-chair of the Multimorbidity Group. Amy is a Lecturer in Mental Health at the University of Manchester and a Chartered Psychologist.

Amy is interested in mental and physical multimorbidity and the identification and treatment of common mental health problems within the context of long-term physical health conditions (LTCs). She has contributed to several national (UK) randomized controlled trials of self-management interventions for patients with LTCs and common mental health problems.

Amy also leads the Long-term Conditions Unit for Psychological Wellbeing Practitioners at the University of Manchester and contributes to teaching on Advance Practice Interventions in Mental Health, MRes Nursing, and MSc Advanced Evidence-Based Practice, as well as the MSc in Clinical and Health Psychology.

Link to University of Manchester Profile:

Dr. Sajjad Siddiqui

Dr Sajjad Siddiqui is a Consultant Psychiatrist who is currently working as Head of Academic Psychiatry & Behavioural Sciences Bakhtawar Amin Medical College Multan.

He has recently joined as a research scientist and head of Liaison Psychiatry in PILL

 His qualifications include:

 MBBS , MRCPSYCH ( London) , CCT in Adult Psychiatry with Endorsement in Liaison Psychiatry, MSc (UK).

He has worked in Uk for almost 14 years as Consultant Psychiatrist in various specialities of Psychiatry including Adult Psychiatry, Liaison Psychiatry , child psychiatry etc. and has seen a wide range of patients with various symptoms and psychiatric illnesses

Mr. Farooque Ahmad

Farooq Ahmad is a Research Associate and Clinical psychologist who has done his BS in Psychology and MS in clinical Psychology from International Islamic University Islamabad in 2019. Farooq is working with PILL since November 2017, his core area of interest is mental health policy research. His other interests includes sustainable development goals (SDGs), suicide and self-harm prevention, digital mental health and multi-morbidity. He is based at the PILL Rawalpindi site in the Institute of Psychiatry Benazir Bhutto Hospital. His biggest achievement includes leading country`s first, All Parliamentary Mental Health Summit in 2020. He has worked on many projects and lead of Depstat, CaPE, and Burns. Farooq has great interest in Multi-morbidity mental health and part of the Coincide project.


Co-adapting and testing an integrated care intervention for diabetes patients with depression in Pakistan.
•    To assess the clinical and cost-effectiveness of adapted integrated care for depressed diabetic patients.
WP 1: Cultural adaptation and co-adaption of the integrated COINCICE Plus Intervention.
WP 2: Patient and Public Involvement and Community Engagement.
WP3: Cluster randomised RCT of COINCIDE Plus with cost-effectiveness analysis.
WP4: Capacity and Capability Building in Diabetes and mental health.

Prof. Maryam Moula Bakhsh

Maryam Moula Bakhsh, Assistant Professor, Department of Respiratory and Critical Care, Dow Institute of Medical Technology, Dow University of Health Sciences (DUHS) since May 2018. She is pursuing her doctoral studies. She was a lecturer at the department of health care management, Jinnah Sindh Medical University. She served as a visiting faculty at the Institute of Health & Business Management and Social Sciences (IOHBMSS), Jinnah Sindh Medical University (JSMU) Karachi, and Sindh Madressatul Islam University, Karachi. She has invited and trained doctors in various workshops related to mechanical ventilation, basic ICU, and surgical skills in tertiary care hospitals. By virtue of her interest and skills in research, as a research supervisor, she is supervising undergraduate and graduate students at DUHS. Her core areas of interest are research and quantitative analysis. She has published research articles in national and international journals. She is a peer reviewer for international and national research journals, including the Science Journal of Public Health, Science Publishing Group, USA, the International Journal of Endorsing Health Science (IJEHSR), and the Journal of Dow University of Health Sciences. She holds expertise in operating numerous research and quantitative analysis software, including SPSS, PLS Smart, R software, Zotero, Endnote & Epi data. Her research interest includes respiratory and critical care, multimorbidity, leadership, E-Learning, and teaching.

Since 2013, she has taught research methodology, research articles, business statistics, biostatistics, and advanced quantitative analysis to students of different academic levels, including undergraduate, MBA, and MS/M.Phil. Recently, she received a teaching excellence certificate from QEC DUHS in collaboration with HEC. She has also qualified for a “Professional Faculty Development” course by QEC, DUHS.

She is also part of Sleep disorder and psychosis study among the Pakistani population.

Multimorbidity Study:

Maryam Moula Bakhsh leading a study on Anxiety and depression among COPD patients in Pakistan. This study is a multi-armed randomized control trial.

Around the globe, COPD affects over 210 million people and is a preeminent cause of morbidity and mortality that eventually causes significant and increasing social and economic burdens. Anxiety and depression are two main comorbidities in COPD patients and are associated with high disability, morbidity, health care expenditure, and mortality. (Laurin et al., 2012).

The evidence for optimal methods of managing anxiety and depression is vague and largely conjectural. Taking into consideration the inconsistent findings and recommendations for the need for research, a multi-armed randomized control trial has been used to conduct study among COPD patients with anxiety and depression. The study participants will be outdoor patients of primary care centers located in Pakistan

Laurin, C., Moullec, G., Bacon, S. L., & Lavoie, K. L. (2012). Impact of Anxiety and Depression on Chronic Obstructive Pulmonary Disease Exacerbation Risk. American Journal of Respiratory and Critical Care Medicine, 185(9), 918–923.

Ms. Sehrish Tofique

Sehrish tofique is a clinical psychologist and assistant driector opertaions at PILL. Her main area of interest is older adults mental health. She is a member of multimorbidity Group. She has joined this group to learn and explore about co morbidities in older adults and to contribute towards developing and evaluating culturally safe interventions for this population.